Physician profile
David B Clause
NPI 1295734465
$2,678.19
in general payments reported to CMS, 2019-2025
8 companies · $51.60 in 2025
The $51.60 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $987 · 2020: $58.44 · 2021: $70.37 · 2022: $83.57 · 2023: $267 · 2024: $1,161 · 2025: $51.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,004 · Travel and Lodging: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,003.80 |
| Travel and Lodging | $475.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,134.63 | 2019-2025 | Mako, Variax, T2 Alpha |
| Allergan, INC. | $259.87 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $83.57 | 2022 | |
| Organogenesis INC. | $78.28 | 2019 | |
| Amgen INC. | $55.91 | 2019 | |
| Pacira Therapeutics, INC. | $32.27 | 2019 | |
| Sanofi-Aventis U.S. LLC | $17.68 | 2019 | |
| Ethicon US, LLC | $15.98 | 2023 | Megadyne |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Clause listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.